Source:http://linkedlifedata.com/resource/pubmed/id/15681708
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-5-17
|
pubmed:abstractText |
We examined the hypothesis that oxidants generated nitroso derivatives, activated latent matrix metalloproteinase (MMP), and induced proteinase-activated receptor 1 (PAR-1), leading to disconnection between the endothelium and myocytes. Administration of cardiospecific tissue inhibitor of metalloproteinase-4 (TIMP-4/CIMP) ameliorated the oxidative-proteolytic stress and endothelial-myocyte uncoupling in chronic heart failure (CHF) in mice. Aortic-vena cava fistula (AVF) was created in 30 male mice (C57BL/6J) and studied at 0-, 2-, and 8-wk AVF. To reverse cardiac remodeling, as measured by MMP activation, purified CIMP was administered by an osmotic minipump subcutaneously after 8-wk AVF, and groups of mice (n = 6 mice/group) were examined after 12 and 16 wk. Levels of PAR-1 in the left ventricle (LV) were increased at 2 and 8 wk (compared with 0 wk of no CIMP treatment) but were normal at 12 and 16 wk after CIMP treatment, as measured by Western blot analysis. Similar results were obtained for LV levels of nitrotyrosine, MMP-2 and -9 activities, and TIMP-1 and -3. However, the levels of TIMP-4, endothelial cell density, and responses of cardiac rings to acetylcholine and bradykinin were attenuated at 2 and 8 wk and normalized after CIMP administration in AVF mice. CIMP induced nitric oxide in microvascular endocardial endothelial cells. The results suggest that nitro generation activated MMP and PAR-1, leading to endothelial-myocyte uncoupling. CIMP treatment normalized PAR-1 expression and ameliorated endothelial-myocyte uncoupling by decreasing oxidant-mediated proteolytic stress in CHF.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
288
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H2770-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15681708-Animals,
pubmed-meshheading:15681708-Arteriovenous Fistula,
pubmed-meshheading:15681708-Disease Models, Animal,
pubmed-meshheading:15681708-Endothelium, Vascular,
pubmed-meshheading:15681708-Heart Failure,
pubmed-meshheading:15681708-Male,
pubmed-meshheading:15681708-Mice,
pubmed-meshheading:15681708-Mice, Inbred C57BL,
pubmed-meshheading:15681708-Muscle Cells,
pubmed-meshheading:15681708-Receptor, PAR-1,
pubmed-meshheading:15681708-Ventricular Function, Left
|
pubmed:year |
2005
|
pubmed:articleTitle |
Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.
|
pubmed:affiliation |
Univ. of Louisville School of Medicine, A-1115, Dept. of Physiology and Biophysics, 500 S. Preston St., Louisville, KY 40202, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|